Jazz Pharmaceuticals plc Insider Trading Activity
Every SEC Form 4 insider transaction reported for Jazz Pharmaceuticals plc (JAZZ), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are JAZZ insiders buying or selling?
In the last 12 months, Jazz Pharmaceuticals plc insiders reported 0 open-market purchases ($0) and 31 sales ($69.8M) — net selling of $69.8M. Since January 2018, Trabud has recorded 266 Form 4 filings for JAZZ: 4 buys ($24.2M) and 262 sells ($157.4M).
Source: SEC EDGAR Form 4
What stands out
- No Jazz Pharmaceuticals plc insider made an open-market purchase in the last 12 months; the 31 reported open-market sales totaled $69.8M.
Key Statistics (January 2018 – Oct 7, 2026)
Total Form 4 filings
266
SEC EDGAR
Insider filers
29
Insider buys (4)
$24.2M
Insider sells (262)
$157.4M
Insider sentiment
Net sellingNet insider flow of $133.2M in net selling since January 2018, and $69.8M in net selling over the last 12 months.
Recent JAZZ insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Renee D Gala | President & CEO | Sale | 2.0K | $236.40 | $472.8K | SEC ↗ |
| Oct 5, 2026 | Bruce C Cozadd | Director | Sale | 6.0K | $230.33 | $1.4M | SEC ↗ |
| Sep 14, 2026 | Neena M Patil | EVP & Chief Legal Officer | Sale | 1.2K | $240.94 | $289.1K | SEC ↗ |
| Sep 10, 2026 | Renee D Gala | President & CEO | Sale | 2.0K | $243.03 | $486.1K | SEC ↗ |
| Sep 2, 2026 | Bruce C Cozadd | Director | Sale | 6.0K | $250.13 | $1.5M | SEC ↗ |
| Aug 31, 2026 | Robert Iannone | EVP, Global Head of R&D & CMO | Sale | 76.9K | $249.70 | $19.2M | SEC ↗ |
| Aug 5, 2026 | Bruce C Cozadd | Director | Sale | 6.0K | $252.98 | $1.5M | SEC ↗ |
| Jul 6, 2026 | Bruce C Cozadd | Director | Sale | 6.0K | $240.47 | $1.4M | SEC ↗ |
| Jun 17, 2026 | Mark Douglas Smith | Director | Sale | 1.2K | $230.55 | $266.7K | SEC ↗ |
| Jun 12, 2026 | Neena M Patil | EVP & Chief Legal Officer | Sale | 1.2K | $231.83 | $278.2K | SEC ↗ |
| Jun 3, 2026 | Bruce C Cozadd | Director | Sale | 6.0K | $235.12 | $1.4M | SEC ↗ |
| Jun 1, 2026 | Neena M Patil | EVP & Chief Legal Officer | Sale | 1.2K | $236.97 | $282.5K | SEC ↗ |
| Jun 1, 2026 | Samantha Pearce | EVP, Chief Commercial Officer | Sale | 6.9K | $235.41 | $1.6M | SEC ↗ |
| May 27, 2026 | Rick E Winningham | Director | Sale | 2.7K | $241.57 | $662.1K | SEC ↗ |
| May 27, 2026 | Heather Ann Mcsharry | Director | Sale | 2.0K | $241.00 | $482.0K | SEC ↗ |
| May 5, 2026 | Bruce C Cozadd | Director | Sale | 6.0K | $203.33 | $1.2M | SEC ↗ |
| Apr 3, 2026 | Bruce C Cozadd | Director | Sale | 6.0K | $190.50 | $1.1M | SEC ↗ |
| Mar 9, 2026 | Patricia Carr | SVP, Chief Accounting Officer | Sale | 1.3K | $182.94 | $235.4K | SEC ↗ |
| Mar 4, 2026 | Bruce C Cozadd | Director | Sale | 6.0K | $186.44 | $1.1M | SEC ↗ |
| Mar 2, 2026 | Norbert G Riedel | Director | Sale | 3.4K | $192.00 | $655.7K | SEC ↗ |
| Mar 2, 2026 | Patricia Carr | SVP, Chief Accounting Officer | Sale | 2.4K | $192.60 | $456.5K | SEC ↗ |
| Mar 2, 2026 | Neena M Patil | EVP & Chief Legal Officer | Sale | 55.6K | $191.56 | $10.7M | SEC ↗ |
| Mar 2, 2026 | Mary Elizabeth Henderson | SVP, Technical Operations | Sale | 5.3K | $194.49 | $1.0M | SEC ↗ |
| Dec 11, 2025 | Mary Elizabeth Henderson | SVP, Technical Operations | Sale | 2.2K | $169.51 | $379.4K | SEC ↗ |
| Dec 9, 2025 | Patricia Carr | SVP, Chief Accounting Officer | Sale | 4.7K | $171.20 | $797.8K | SEC ↗ |
Showing the 25 most recent of 266 Form 4 filings for Jazz Pharmaceuticals plc.
Most active JAZZ insiders
- Bruce C Cozadd70 filings
- Patricia Carr28 filings
- Matthew P. Young15 filings
- Michael Patrick Miller15 filings
- Neena M Patil13 filings
Ask anything about JAZZ insider activity
Use Trabud's AI agent to query Jazz Pharmaceuticals plc's Form 4 history in plain English — "Show me JAZZ CEO purchases this year" or compare it against any other ticker.
Open the AI agentJAZZ insider trading FAQ
Are Jazz Pharmaceuticals plc insiders buying or selling?
In the last 12 months, Jazz Pharmaceuticals plc insiders reported 0 open-market purchases ($0) and 31 sales ($69.8M) — net selling of $69.8M. Since January 2018, Trabud has recorded 266 Form 4 filings for JAZZ: 4 buys ($24.2M) and 262 sells ($157.4M). Over the full record that is net selling of $133.2M.
How many insiders trade JAZZ stock?
29 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Jazz Pharmaceuticals plc. The most recent filing was accepted on Oct 7, 2026.
Where does Trabud get JAZZ insider trading data?
All JAZZ insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.